Filters

FRA1 (Ser265) Antibody

FRA1 (Ser265) Antibody size: 0.1ml 281

Price 281
Size 0.1ml
Long nameFRA1 (Ser265) Primary Polyclonal Antibody
Also known asFRA1 (Ser265) PAb
CategoryPrimary Antibodies
ConjugationUnconjugated
Target AntigenFRA1 Ser265
Specificity This phosphorylation site is homologous to Ser267 in Mouse and Ser269 in Rat, This is a highly specific antibody against FRA1 Ser265
Modification(s)Phosphorylation
Modification site(s)Ser265
ClonalityPolyclonal antibody
Clone numberPolyclonal antibody
Concentration1ug per 1ul
Immunogen range230-271/271
Subcellular locationNucleus
SourceKLH conjugated synthetic phosphopeptide derived from human FRA1 around the phosphorylation site of Ser265
Gene ID number8061
Swiss ProtP15407
Tested Applications IF(IHC-P), IHC-P, WB
Recommended dilutions IF(IHC-P)(1:50-200), IHC-P(1:100-500), WB(1:100-1000)
Cross reactivity Mouse, Rat, Human
Cross reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the target antigen As such, FOSB, FOSL1, These genes encode leucine zipper proteins that can dimerize with proteins of the JUN family, [provided by RefSeq], and FOSL2, and transformation, differentiation, the FOS proteins have been implicated as regulators of cell proliferation, thereby forming the transcription factor complex AP-1, The Fos gene family consists of 4 members: FOS
Purification methodThis antibody was purified via Protein A
Storage conditions 50% glycerol and 0, Store at -20°, 09% sodium azide, C for up to 1 year, Keep the antibody in aqueous buffered solution containing 1% BSA
Synonym names FOSL1, FRA1, Fos-related antigen 1, fra-1, FRA
PropertiesC, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Unconjugated Antibodies they should be stored frozen at - 24°
Gene targetFRA1 (Ser265)
Short nameFRA1 (Ser265) Antibody
Technique antibodies against human proteins, antibodies for, Antibody
Alternative nameFRA1 (Ser265) (Antibody to)
Alternative techniqueantibodies

Subscribe to our Newsletter